1. Home
  2. DUO vs NKGN Comparison

DUO vs NKGN Comparison

Compare DUO & NKGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DUO
  • NKGN
  • Stock Information
  • Founded
  • DUO 2011
  • NKGN 2017
  • Country
  • DUO China
  • NKGN United States
  • Employees
  • DUO N/A
  • NKGN N/A
  • Industry
  • DUO Real Estate
  • NKGN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • DUO Finance
  • NKGN Health Care
  • Exchange
  • DUO Nasdaq
  • NKGN Nasdaq
  • Market Cap
  • DUO 14.6M
  • NKGN 14.1M
  • IPO Year
  • DUO 2019
  • NKGN N/A
  • Fundamental
  • Price
  • DUO $0.69
  • NKGN $0.50
  • Analyst Decision
  • DUO
  • NKGN
  • Analyst Count
  • DUO 0
  • NKGN 0
  • Target Price
  • DUO N/A
  • NKGN N/A
  • AVG Volume (30 Days)
  • DUO 17.2M
  • NKGN 711.5K
  • Earning Date
  • DUO 08-30-2024
  • NKGN 12-24-2024
  • Dividend Yield
  • DUO N/A
  • NKGN N/A
  • EPS Growth
  • DUO N/A
  • NKGN N/A
  • EPS
  • DUO N/A
  • NKGN N/A
  • Revenue
  • DUO $37,352,654.00
  • NKGN N/A
  • Revenue This Year
  • DUO N/A
  • NKGN N/A
  • Revenue Next Year
  • DUO N/A
  • NKGN N/A
  • P/E Ratio
  • DUO N/A
  • NKGN N/A
  • Revenue Growth
  • DUO 6.61
  • NKGN N/A
  • 52 Week Low
  • DUO $0.32
  • NKGN $0.20
  • 52 Week High
  • DUO $4.67
  • NKGN $4.06
  • Technical
  • Relative Strength Index (RSI)
  • DUO 46.11
  • NKGN 59.45
  • Support Level
  • DUO $0.67
  • NKGN $0.45
  • Resistance Level
  • DUO $0.81
  • NKGN $0.55
  • Average True Range (ATR)
  • DUO 0.14
  • NKGN 0.07
  • MACD
  • DUO 0.03
  • NKGN 0.00
  • Stochastic Oscillator
  • DUO 15.19
  • NKGN 47.48

About DUO Fangdd Network Group Ltd.

Fangdd Network Group Ltd is an investment holding company. Through its subsidiaries, It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.

About NKGN NKGen Biotech Inc.

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.

Share on Social Networks: